PCOS is now PMOS to address the inaccuracy of the old name, which overemphasized ovarian cysts.
The name change followed a 14-year global collaboration involving experts, patients, and 56 organizations, including the Endocrine Society.
PMOS is characterized by hormonal imbalances affecting various systems, not just the ovaries.
The new name seeks to improve diagnosis, treatment, and awareness of the condition, which often goes undiagnosed in up to 70% of cases.
The transition to the new name will occur over three years, with full implementation expected by 2028.
The decision to rename PCOS to PMOS stems from the recognition that the term "polycystic" is misleading. It inaccurately suggests that individuals with the condition have abnormal cysts on their ovaries. Research has shown that PMOS patients do not necessarily have more pathological cysts than those without the condition. Instead, they may have a high number of arrested follicles, which are not the same as cysts.
The new name, Polyendocrine Metabolic Ovarian Syndrome, highlights the hormonal and metabolic dimensions of the condition, which were previously underemphasized. This shift aims to encourage a more holistic approach to diagnosis and treatment, addressing the diverse range of symptoms and complications associated with PMOS. The collaborative effort behind the name change underscores the importance of patient involvement and international cooperation in advancing medical knowledge and improving healthcare outcomes.
The renaming process involved extensive surveys, workshops, and consultations with patients and healthcare professionals worldwide. This inclusive approach ensured that the new name was not only scientifically accurate but also culturally sensitive and acceptable to diverse populations. The three-year transition period will allow for widespread education and awareness campaigns to familiarize healthcare providers, patients, and the general public with the new terminology.
Q: Why was PCOS renamed to PMOS?
The old name was inaccurate and focused too much on ovarian cysts, which are not always present in individuals with the condition. The new name better reflects the hormonal and metabolic aspects of the syndrome.
Q: How many people are affected by PMOS?
PMOS affects approximately 1 in 8 women worldwide, or more than 170 million people.
Q: When will the new name be fully implemented?
The transition to the new name will take three years, with full implementation expected by the 2028 International Guideline update.
PCOS has been renamed PMOS to provide a more accurate and comprehensive understanding of the condition.
The new name reflects the hormonal and metabolic complexities of the syndrome, beyond just the ovaries.
If you have been diagnosed with PCOS, be aware of the name change and seek information about PMOS to better understand your condition.
The renaming effort aims to improve diagnosis, treatment, and overall care for individuals with this syndrome.
Do you think this name change will lead to better understanding and treatment of this condition? Share your thoughts in the comments below!
Share this article with others who need to stay ahead of this trend!
⚠ Disclaimer: Yanuki provides article summaries and links for reference only. Yanuki does not endorse, verify, or guarantee the accuracy of third-party sources. Please review original sources and verify information independently. Managed by the Yanuki Data Engine. Full Disclaimer